Alzamend Neuro, Inc.
50 W. Broadway
Salt Lake City
About Alzamend Neuro, Inc.Alzamend Neuro is a development stage biotechnology company which has licensed a patented mutant peptide developed by Dr. Chuanhai Cao at the college of Pharmacy of the University of South Florida (USF) and USF- Health Byrd Alzheimer’s Institute to develop a cell based therapeutic vaccine as an immunotherapy to prevent or slowdown Alzheimer’s disease. This therapy is not only target on the pathological molecule that is associated to AD, but also is able to fix the impaired immune system associated to AD development
CEO: Phil Mansour
CTO: William B. Horne
Chairman: Milton “Todd” Ault
Please click here for Alzamend Neuro's job opportunities.
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.